Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Noriko Ihana-Sugiyama; Ritsuko Yamamoto-Honda; Takehiro Sugiyama; Tetsuro Tsujimoto; Masafumi Kakei; Mitsuhiko Noda

doi:10.12659/MSMBR.902218

28 February 2017 : Clinical Research

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Noriko Ihana-Sugiyama^{ABCDEF 1}, Ritsuko Yamamoto-Honda^{ACDEF 1,2}, Takehiro Sugiyama^{CDE 3}, Tetsuro Tsujimoto^{D 1}, Masafumi Kakei^{CDE 4}, Mitsuhiko Noda^{ADE 5*}

DOI: 10.12659/MSMBR.902218

Med Sci Monit Basic Res 2017; 23:36-44

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Your Privacy